SO
NTLA icon

STRS Ohio’s Intellia Therapeutics NTLA Stock Holding History

STRS Ohio’s Portfolio NTLA Stock Details NTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,000
Closed -$30K – 1999
2023
Q4 		$30K Sell
1,000
-5,900
-86% -$170K ﹤0.01% 1823
2023
Q3 		$218K Hold
6,900
– – ﹤0.01% 1548
2023
Q2 		$281K Buy
6,900
+1,500
+28% +$60.8K ﹤0.01% 1503
2023
Q1 		$201K Sell
5,400
-8,200
-60% -$322K ﹤0.01% 1597
2022
Q4 		$474K Sell
13,600
-2,300
-14% -$109K ﹤0.01% 1349
2022
Q3 		$889K Hold
15,900
– – ﹤0.01% 971
2022
Q2 		$822K Buy
15,900
+900
+6% +$45.7K ﹤0.01% 1035
2022
Q1 		$1.09M Sell
15,000
-600
-4% -$50.8K ﹤0.01% 985
2021
Q4 		$1.84M Sell
15,600
-1,400
-8% -$175K 0.01% 778
2021
Q3 		$2.28M Buy
17,000
+700
+4% +$106K 0.01% 654
2021
Q2 		$2.64M Buy
16,300
+3,000
+23% +$234K 0.01% 643
2021
Q1 		$1.07M Buy
13,300
+2,400
+22% +$161K ﹤0.01% 1123
2020
Q4 		$592K Buy
+10,900
New +$396K ﹤0.01% 1378
2017
Q1 		– Sell
-3,200
Closed -$42.9K – 1913
2016
Q4 		$41K Hold
3,200
– – ﹤0.01% 1814
2016
Q3 		$54K Buy
3,200
+900
+39% +$17.4K ﹤0.01% 1753
2016
Q2 		$49K Buy
+2,300
New +$61.2K ﹤0.01% 1774

Other funds holding NTLA

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

STRS Ohio's NTLA Position: Q1 2024 in Review

STRS Ohio sold out of Intellia Therapeutics (NTLA) in Q1 2024, closing a stake of 1,000 shares — an estimated $30K sold.

STRS Ohio first reported a position in NTLA in Q2 2016 and held it in 16 quarters. The position peaked at $2.64M in Q2 2021. 284 funds tracked by Wall St. Rank hold NTLA as of Q1 2024.

  • STRS Ohio reported no remaining Intellia Therapeutics position as of Q1 2024 after selling out during the quarter.
  • STRS Ohio sold 1,000 Intellia Therapeutics shares in Q1 2024, an estimated $30K.
  • STRS Ohio first reported a position in Intellia Therapeutics in Q2 2016 and held it in 16 quarters.
  • STRS Ohio's Intellia Therapeutics position peaked at $2.64M in Q2 2021.
  • 284 funds tracked by Wall St. Rank held Intellia Therapeutics as of Q1 2024.

Based on STRS Ohio's 13F filing for Q1 2024, filed 13 May 2024.